ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways

被引:97
|
作者
Heo, Jung Sun [1 ]
Han, Ho Jae [1 ]
机构
[1] Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Biotherapy Human Resources Ctr, Kwangju 500757, South Korea
关键词
ATP; mitogen-activated protein kinases; phosphatidylinositol; 3-kinase/Akt; protein kinase C; embryonic stem cells;
D O I
10.1634/stemcells.2005-0588
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This study investigated the effect of ATP and its related signal cascades on the proliferation of mouse ESCs. ATP increased the level of [H-3] thymidine/5-bromo-2'-deoxyuridine incorporation and the number of cells in both a time- and dose-dependent manner. AMP-CPP( a P2X(1) and P2X(3) agonist), ATP-gamma S ( a P2Y agonist), and 2-methylthio-ATP ( a P2X and P2Y agonist) stimulated [H-3] thymidine incorporation. P2 purinoceptor antagonists ( suramin, reactive blue 2) inhibited the ATP-induced increase in [ 3H] thymidine incorporation. Reverse transcription-polymerase chain reaction analysis revealed P2X(3), P2X(4), P2Y(1), and P2Y(2) expression in mouse ESCs. Adenylate cyclase inhibitor (SQ 22536), phospholipase C inhibitors ( neomycin or U 73122), and protein kinase C (PKC) inhibitors ( bisindolylmaleimide I or staurosporine) inhibited the ATP-induced increase in [H-3] thymidine incorporation. ATP increased the level of intracellular cAMP and inositol phosphates. ATP translocated PKC alpha, delta, and zeta from the cytosol to the membrane compartment. ATP and its agonists increased [Ca2+](i). In addition, the ATP-induced increase in [H-3] thymidine incorporation was completely inhibited by a combination of EGTA ( extracellular Ca2+ chelator) and 1,2-bis(2-aminophenoxy) ethane-N, N,N',N'-tetraacetic acid (BAPTA)-AM ( intracellular Ca2+ chelator). ATP phosphorylated Akt and p44/42 mitogen-activated protein kinases ( MAPKs) in a time- dependent manner, and either suramin or reactive blue 2 (RB2) blocked the ATP-induced phosphorylation of Akt. Suramin, RB2, the phosphatidylinositol 3-kinase (PI3K) inhibitor ( wortmannin), or the Akt inhibitor inhibited the phosphorylation of p44/42 MAPKs. The ATP-induced increase in [H-3] thymidine incorporation was inhibited by wortmannin, the Akt inhibitor, and the MAPK kinase inhibitor (PD 98059). Suramin, RB2, PD 98059, and wortmannin blocked the ATP-induced increase in the cyclin D1, cyclin E, cyclin-dependent kinase (CDK) 2, and CDK4 levels. In conclusion, ATP stimulates mouse ESC proliferation through PKC, PI3K/Akt, and MAPKs via the P2 purinoceptors.
引用
收藏
页码:2637 / 2648
页数:12
相关论文
共 50 条
  • [1] Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis
    Marushige, K
    Marushige, Y
    [J]. ANTICANCER RESEARCH, 1999, 19 (5B) : 3865 - 3871
  • [2] Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
    Xiao, GH
    Jeffers, M
    Bellacosa, A
    Mitsuuchi, Y
    Vande Woude, GF
    Testa, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 247 - 252
  • [3] Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways
    Wang, Y
    Wei, X
    Xiao, X
    Hui, RT
    Card, JW
    Carey, MA
    Wang, DW
    Zeldin, DC
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02): : 522 - 532
  • [4] Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen-activated protein kinase kinase signaling pathways
    Hu, Shan
    Huang, Liming
    Meng, Liwei
    Sun, He
    Zhang, Wei
    Xu, Yingchun
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 6745 - 6751
  • [5] Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase
    Chun, YK
    Kim, J
    Kwon, S
    Choi, SH
    Hong, F
    Moon, KA
    Kim, JM
    Choi, SL
    Kim, BS
    Ha, J
    Kim, SS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (02) : 502 - 507
  • [6] Amphiregulin regulates odontogenic differentiation of dental pulp stem cells by activation of mitogen-activated protein kinase and the phosphatidylinositol 3-kinase signaling pathways
    Junqing Li
    Zhihua Wang
    Juan Wang
    Qian Guo
    Yi Fu
    Zihan Dai
    Minghao Wang
    Yu Bai
    Xin Liu
    Paul R. Cooper
    Jiayuan Wu
    Wenxi He
    [J]. Stem Cell Research & Therapy, 13
  • [7] Amphiregulin regulates odontogenic differentiation of dental pulp stem cells by activation of mitogen-activated protein kinase and the phosphatidylinositol 3-kinase signaling pathways
    Li, Junqing
    Wang, Zhihua
    Wang, Juan
    Guo, Qian
    Fu, Yi
    Dai, Zihan
    Wang, Minghao
    Bai, Yu
    Liu, Xin
    Cooper, Paul R.
    Wu, Jiayuan
    He, Wenxi
    [J]. STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [8] Genetic Alterations in the Ras/Raf/Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in the Follicular Variant of Papillary Thyroid Carcinoma
    Santarpia, Libero
    Myers, Jeffrey N.
    Sherman, Steven I.
    Trimarchi, Francesco
    Clayman, Gary L.
    El-Naggar, Adel K.
    [J]. CANCER, 2010, 116 (12) : 2974 - 2983
  • [9] Human Epididymis Protein 4 Inhibits Proliferation of Human Ovarian Cancer Cells Via the Mitogen-Activated Protein Kinase and Phosphoinositide 3-Kinase/AKT Pathways
    Kong, Xiuli
    Chang, Xiaohong
    Cheng, Hongyan
    Ma, RuiQiong
    Ye, Xue
    Cui, Heng
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 427 - 436
  • [10] Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells
    Edwards, LA
    Verreault, M
    Thiessen, B
    Dragowska, WH
    Hu, YP
    Yeung, JHF
    Dedhar, S
    Bally, MB
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) : 645 - 654